Skip to main content
MorphoSys AG logo

MorphoSys AG — Investor Relations & Filings

Ticker · MOR ISIN · DE000A3H2XW6 LEI · 529900493806K77LRE72 F Manufacturing
Open in API
Filings indexed 1,418 across all filing types
Latest filing 2024-04-22 Declaration of Voting R…
Country DE Germany
Listing F MOR

About MorphoSys AG

https://www.morphosys.com/

MorphoSys AG is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, primarily for cancer patients. The company specializes in creating therapeutic monoclonal antibodies, utilizing its long-standing expertise and proprietary technology platforms to generate fully human antibodies. Its research and development efforts are concentrated on building a pipeline of novel treatments to address significant unmet medical needs in oncology. In February 2024, Novartis entered into an agreement to acquire MorphoSys, aiming to integrate its antibody technologies and oncology pipeline.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in voting rights percentages held by Morgan Stanley in MorphoSys AG, referencing specific sections of the German Securities Trading Act (WpHG). This directly aligns with the definition of reporting changes in significant share ownership thresholds, which corresponds to the Major Shareholding Notification category (MRQ). Although the header mentions 'Voting Rights Announcements', the content structure (reporting thresholds crossed, total positions, details of instruments) is characteristic of a major holding disclosure.
2024-04-22 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership, specifically detailing the 'New' and 'Previous notification' percentages of voting rights attached to shares and instruments, referencing German Securities Trading Act (WpHG) sections (Article 40, Sec. 33, 34, 38). This content directly corresponds to the notification of changes in significant share ownership levels, which maps precisely to the Major Shareholding Notification category (MRQ). Although it is a regulatory announcement disseminated via EQS, the specific nature of the content (voting rights change) overrides the general 'RNS' fallback.
2024-04-19 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership ('Notification of Major Holdings') by a legal entity (Barclays PLC) in MorphoSys AG, referencing specific German securities law articles (WpHG). This directly corresponds to the definition of a notification regarding changes in significant share ownership thresholds, which is classified as Major Shareholding Notification (MRQ). Although it is a regulatory filing, MRQ is more specific than the general RNS fallback.
2024-04-19 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in voting rights percentages, acquisition/disposal of shares, and details of instruments (options, swaps) held by a major shareholder (Morgan Stanley) in MorphoSys AG. This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership thresholds. The German regulatory context (WpHG) further confirms this is a mandatory disclosure related to share ownership changes. Therefore, the appropriate code is MRQ.
2024-04-19 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in the percentage of voting rights held by a major shareholder (Novartis AG/Novartis BidCo AG) in MorphoSys AG, referencing German Securities Trading Act (WpHG) sections. This directly corresponds to the definition of a notification of changes in significant share ownership levels crossing thresholds, which is classified as Major Shareholding Notification (MRQ). Although the header mentions 'Voting Rights Announcements', the content is a formal disclosure of shareholding changes, fitting MRQ better than DVA (which is for voting results) or DIRS (which is for director's personal trades).
2024-04-18 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Notification of Major Holdings' and explicitly references compliance with Article 40, Section 1 of the WpHG (German Securities Trading Act). It details the acquisition/disposal of shares with voting rights by BNP PARIBAS SA, showing changes in percentage holdings (e.g., moving from 5.09% to 4.06%). This type of filing, which reports changes in significant share ownership thresholds, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although the header mentions 'Voting Rights Announcements', the content is specifically about crossing a major holding threshold, which is best classified as MRQ.
2024-04-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.